Literature DB >> 3355761

A 72 kD trophoblast glycoprotein defined by a monoclonal antibody.

N Hole1, P L Stern.   

Abstract

A novel trophoblast cell surface antigen has been defined by a monoclonal antibody 5T4, raised following immunisation with wheat germ agglutinin (WGA) purified glycoproteins from deoxycholate (DOC) solubilised human syncytiotrophoblast plasma membrane (StMPM). The distribution of the antigen was determined by indirect immunoperoxidase staining of sections of normal organ and placental tissues as well as immunofluorescence and radiobinding assays with a wide variety of cell lines representing differing normal and tumour cell types. In frozen sections of normal full term placenta, 5T4 is strongly expressed only by the syncytiotrophoblast, some extravillous cytotrophoblast and the amniotic epithelium. The 5T4 antigen is apparently not expressed by any maternal component of the placenta nor is it detected in adult liver, lung, bronchus, heart, testis, ovary, brain, or muscle. The antigen is apparently expressed by several specialised epithelia. Immunoprecipitation of radiolabelled StMPM indicated that 5T4 molecules are glycoproteins of mol. wt of approximately 72 kD on SDS-PAGE. 5T4 antigen is selectively expressed by diverse tumour cell lines, including those of developmental origin. The molecular characteristics, relatively restricted normal tissue distribution and expression by certain tumour cell types make this antigen worthy of future study for use as a diagnostic marker of malignancy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3355761      PMCID: PMC2246524          DOI: 10.1038/bjc.1988.53

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  42 in total

1.  Culture characteristics of four permanent lines of human cancer cells.

Authors:  A E MOORE; L SABACHEWSKY; H W TOOLAN
Journal:  Cancer Res       Date:  1955-10       Impact factor: 12.701

2.  K562--a human erythroleukemic cell line.

Authors:  L C Andersson; K Nilsson; C G Gahmberg
Journal:  Int J Cancer       Date:  1979-02       Impact factor: 7.396

3.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes.

Authors:  J Minowada; T Onuma; G E Moore
Journal:  J Natl Cancer Inst       Date:  1972-09       Impact factor: 13.506

4.  Characteristics of a human diploid cell designated MRC-5.

Authors:  J P Jacobs; C M Jones; J P Baille
Journal:  Nature       Date:  1970-07-11       Impact factor: 49.962

5.  Surgace IgM specificity on cells derived from a Burkitt's lymphoma.

Authors:  E Klein; G Klein; J S Nadkarni; J J Nadkarni; H Wigzell; P Clifford
Journal:  Lancet       Date:  1967-11-18       Impact factor: 79.321

6.  Preparation of human placental villous surface membrane.

Authors:  N C Smith; M G Brush; S Luckett
Journal:  Nature       Date:  1974-11-22       Impact factor: 49.962

7.  Helix pomatia A hemagglutinin: selectivity of binding to lymphocyte surface glycoproteins on T cells and certain B cells.

Authors:  B Axelsson; A Kimura; S Hammarström; H Wigzell; K Nilsson; H Mellstedt
Journal:  Eur J Immunol       Date:  1978-11       Impact factor: 5.532

8.  Monoclonal antibodies to human syncytiotrophoblast.

Authors:  C A Sunderland; C W Redman; G M Stirrat
Journal:  Immunology       Date:  1981-07       Impact factor: 7.397

9.  Nerve growth factor receptors on human melanoma cells in culture.

Authors:  R N Fabricant; J E De Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

10.  Ten human carcinoma cell lines derived from squamous carcinomas of the head and neck.

Authors:  D M Easty; G C Easty; R L Carter; P Monaghan; L J Butler
Journal:  Br J Cancer       Date:  1981-06       Impact factor: 7.640

View more
  31 in total

1.  CD8+ T-cell clones specific for the 5T4 antigen target renal cell carcinoma tumor-initiating cells in a murine xenograft model.

Authors:  Scott S Tykodi; Shoko Satoh; Janise D Deming; Jeffrey Chou; Richard Harrop; Edus H Warren
Journal:  J Immunother       Date:  2012-09       Impact factor: 4.456

2.  Glycosylation and epitope mapping of the 5T4 glycoprotein oncofoetal antigen.

Authors:  David M Shaw; Andrew M Woods; Kevin A Myers; Caroline Westwater; Veena Rahi-Saund; Michael J Davies; David V Renouf; Elizabeth F Hounsell; Peter L Stern
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

3.  Trophoblast Glycoprotein (TPGB/5T4) in Human Placenta: Expression, Regulation, and Presence in Extracellular Microvesicles and Exosomes.

Authors:  S M K Alam; S Jasti; S K Kshirsagar; D S Tannetta; R A Dragovic; C W Redman; I L Sargent; H C Hodes; T L Nauser; T Fortes; A M Filler; K Behan; D R Martin; T A Fields; B K Petroff; M G Petroff
Journal:  Reprod Sci       Date:  2017-05-08       Impact factor: 3.060

4.  Characterization of the murine 5T4 oncofoetal antigen: a target for immunotherapy in cancer.

Authors:  Andrew M Woods; Who W Wang; David M Shaw; Christopher M Ward; Miles W Carroll; Buddug R Rees; Peter L Stern
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

5.  Trophoblast glycoprotein: possible candidate mediating podocyte injuries in glomerulonephritis.

Authors:  Taichi Murakami; Hideharu Abe; Kojiro Nagai; Tatsuya Tominaga; Norimichi Takamatsu; Toshikazu Araoka; Seiji Kishi; Toshikazu Takahashi; Akira Mima; Yoshimi Takai; Jeffrey B Kopp; Toshio Doi
Journal:  Am J Nephrol       Date:  2010-10-27       Impact factor: 3.754

Review 6.  Development of modified vaccinia Ankara-5T4 as specific immunotherapy for advanced human cancer.

Authors:  Scott S Tykodi; John A Thompson
Journal:  Expert Opin Biol Ther       Date:  2008-12       Impact factor: 4.388

7.  CXCR4 mediated chemotaxis is regulated by 5T4 oncofetal glycoprotein in mouse embryonic cells.

Authors:  Thomas D Southgate; Owen J McGinn; Fernanda V Castro; Andrzej J Rutkowski; Mariam Al-Muftah; Georgi Marinov; Graeme J Smethurst; David Shaw; Christopher M Ward; Crispin J Miller; Peter L Stern
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

8.  Phase I dose escalation, pharmacokinetic and pharmacodynamic study of naptumomab estafenatox alone in patients with advanced cancer and with docetaxel in patients with advanced non-small-cell lung cancer.

Authors:  Hossein Borghaei; Katherine Alpaugh; Gunnar Hedlund; Göran Forsberg; Corey Langer; Andre Rogatko; Robert Hawkins; Svein Dueland; Ulrik Lassen; Roger B Cohen
Journal:  J Clin Oncol       Date:  2009-07-27       Impact factor: 44.544

9.  Trophoblast glycoprotein recognised by monoclonal antibody 5T4 maps to human chromosome 6q14-q15.

Authors:  J M Boyle; K H Grzeschik; P R Heath; J E Morten; P L Stern
Journal:  Hum Genet       Date:  1990-04       Impact factor: 4.132

10.  Expression and distribution of trophoblast glycoprotein in the mouse retina.

Authors:  Colin M Wakeham; Gaoying Ren; Catherine W Morgans
Journal:  J Comp Neurol       Date:  2020-01-06       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.